And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | April 8, 2020

Cynosure Names David Long Global Chief Financial Officer

David Long is Cynosure’s new Chief Financial Officer, effective immediately. Until recently, Long served as CFO at Corindus Vascular Robotics, Inc., where he brought the company public and, ultimately, navigated its strategic sale...

Read More

News | April 7, 2020

Rosacea Awareness Month Brings Focus to Common Skin Disease

It’s Rosacea Awareness Month, and the National Rosacea Society (NRS) continues to educate the public on this potentially serious condition estimated to affect more than 16 million Americans. “Although the occurrence of...

Read More

News | April 7, 2020

COVID-19 By the Numbers: April 7 Edition

The peak for medical resource utilization related to COVID-19 in the US is estimated to hit on April 15, and deaths will peak on April 16, according to the Institute for Health Metrics and Evaluation (IHME), an independent population...

Read More

News | April 4, 2020

Lessons from Italy: Understanding and Recognizing Potential Skin Manifestations in COVID-19

Italian dermatologists report that about 20 percent of COVID-19 patients may develop skin manifestations including red rashes. Their findings appear in Journal of the European Academy of Dermatology Venereology. The...

Read More

News | April 3, 2020

Dermavant Completes Patient Enrollment for Two Phase 3 Clinical Trials of Tapinarof for Psoriasis

Dermavant Sciences completed patient enrollment in PSOARING 1 and PSOARING 2 clinical trials of tapinarof, a potential first-in-class, once-daily topical therapeutic aryl hydrocarbon receptor modulating agent (TAMA), in adult patients...

Read More

Advertisement

The Latest News

Advertisement

View more